Thermo Fisher Scientific Inc. ( TMO) - Key Metrics
TMO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $32.49 | $5.25 | $9.19 | $7.96 |
| 2025Q3 | $29.42 | $4.28 | $5.92 | $4.85 |
| 2025Q2 | $28.72 | $4.28 | $3.70 | $2.92 |
| 2025Q1 | $27.42 | $3.99 | $1.91 | $0.96 |
TMO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 8.20% | 27.58 |
| 2025Q3 | 10.09% | 27.15 |
| 2025Q2 | 10.02% | 23.86 |
| 2025Q1 | 9.89% | 31.36 |
TMO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.46% | ? |
| 2025Q4 | 1.37% | 0.07% |
| 2025Q3 | 1.05% | 0.09% |
| 2025Q2 | 0.72% | 0.10% |
| 2025Q1 | 0.19% | 0.08% |
TMO
List: Challengers
Price: $473.95
Dividend Yield: 0.38%
Forward Dividend Yield: 0.40%
Payout Ratio: 9.69%
Dividend Per Share: 1.88 USD
Earnings Per Share: 18.20 USD
P/E Ratio: 25.65
Exchange: NYQ
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 1.2 million
Ebitda: 1.6 billionMarket Capitalization: 173.5 billion
Average Dividend Frequency: 4
Years Paying Dividends: 15
DGR3: 13.58%
DGR5: 14.89%
DGR10: 10.75%